NCT05142696 2026-03-17A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and AtezolizumabNovartisPhase 1/2 Active not recruiting24 enrolled
NCT04699838 2026-01-02Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung CancerBig Ten Cancer Research ConsortiumPhase 2 Recruiting30 enrolled